Curreio, Inc. is a pioneering company in the field of drug discovery, leveraging advanced cryo-electron microscopy for structural analysis. The company collaborates with academic institutions and research organizations to conduct joint research and provide consultancy services. Curreio operates primarily in the pharmaceutical and biotechnology sectors, serving clients who are focused on developing new drugs and therapies. The business model revolves around offering specialized research services and intellectual property licensing, generating revenue through service fees and royalties. Curreio's unique approach allows for the detailed visualization of molecular structures, facilitating the design of more effective drugs.

Keywords: cryo-electron microscopy, drug discovery, structural analysis, pharmaceutical, biotechnology, research collaboration, consultancy, intellectual property, molecular visualization, advanced microscopy.